Finance

Mga Listahan
300261:SHE
ABA Chemicals Corp
CNÂ¥4.63
+0.65%
(+0.030) 1D
Okt 16, 3:04:58 PM GMT+8  ·   CNY
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa 300261...
Buksan
CNÂ¥4.63
Mataas
CNÂ¥4.77
Mababa
CNÂ¥4.59
Mkt. cap
4.46B
Avg. na dami
13.59M
Dami
8.76M
Mataas nang 52-wk
CNÂ¥8.66
Mababa nang 52-wk
CNÂ¥4.27
EPS
-CNÂ¥0.33
Mga natitirang share
963.31M
Bilang ng mga empleyado
1K
Buksan
CNÂ¥4.63
Mataas
CNÂ¥4.77
Mababa
CNÂ¥4.59
Mkt. cap
4.46B
Avg. na dami
13.59M
Dami
8.76M
Mataas nang 52-wk
CNÂ¥8.66
Mababa nang 52-wk
CNÂ¥4.27
EPS
-CNÂ¥0.33
Mga natitirang share
963.31M
Bilang ng mga empleyado
1K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia
Tungkol sa ABA Chemicals Corp
CEO-
Mga Empleyado1.2K
ItinatagEne 13, 2006
Headquarters-
SektorSpeciality chemicals
Mga nakaraang ulatLahat ng value sa CNY
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa CNY
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
334.69M
310.82M
303.59M
293.25M
Gastusin sa mga naibentang produkto
248.45M
300.89M
286.91M
289.14M
Halaga ng kita
248.45M
300.89M
286.91M
289.14M
Mga gastos sa pananaliksik at pag-develop
29.18M
28.68M
20.19M
22.86M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
48.48M
37.47M
41.02M
41.59M
Gastos sa pagpapatakbo
81.42M
103.89M
62.77M
66.53M
Kabuuang gastos sa pagpapatakbo
329.87M
404.78M
349.68M
355.67M
Kita sa pagpapatakbo
4.82M
-93.96M
-46.09M
-62.42M
Iba pang hindi kita sa pagpapatakbo
15.52M
-16.13M
-10.85M
9.81M
EBT na may mga hindi karaniwang item
-2.79M
-177.93M
-73.15M
-115.16M
EBT na hindi kasama ang mga hindi karaniwang item
-1.61M
-124.19M
-66.74M
-83.81M
Gastos sa buwis sa kita
-3.44M
-6.13M
-14.24M
-13.04M
Epektibong rate ng buwis
123.57%
3.45%
19.47%
11.32%
Iba pang gastos sa pagpapatakbo
2.79M
-849.91K
2.71M
3.05M
Net na kita
1.75M
-152.59M
-57.58M
-101.81M
Margin ng kabuuang kita
0.52%
-49.09%
-18.97%
-34.72%
Kita bawat share
-
-
-
-
Kita sa interes at investment
5.04M
-
568.87K
77.43K
Gastos sa interes
-9.72M
-15.90M
-10.37M
-13.65M
Mga net na gastos sa interes
-4.68M
-15.90M
-9.80M
-13.58M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
38.18M
-59.20M
-11.33M
-28.50M
Kita o pagkalugi mula sa pagbebenta ng mga asset
110.13K
-161.52K
-
-258.93K
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google